MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / Berwick’s appointment a boon for medical device makers?

Berwick’s appointment a boon for medical device makers?

April 1, 2010 By Edward Berger Leave a Comment

If you’ve been studying the contents of the recently passed healthcare reform legislation, and you’ve looked in vain for the elements that emphatically implement systemic cost control and improvements in quality of care, President Barack Obama’s nomination of Dr. Donald Berwick as administrator of the Centers for Medicare and Medicaid Services comes as very good news indeed. With this nomination, the president has demonstrated that he fully understands that insurance reform alone — important as it may be — won’t fix the ills besetting U.S. healthcare, and that he is committed to an ongoing process to rationalize and improve the way our healthcare is organized, provided and evaluated.

Administrator of CMS is the most critical healthcare post in the country. As summarized in the Boston Globe, the agency has 4,500 employees, an annual budget of $780 billion and funds the healthcare of more than 100 million primarily elderly or low income Americans — a number that will increase substantially as more and more Baby Boomers qualify for Medicare at age 65 and the Medicaid benefit expansion built into healthcare reform comes on line. The position offers enormous potential for leadership, but requires daunting administrative and political skills. Since its founding in 1977, CMS has had enormous turnover in the administrator’s office, with 10 different presidential appointees approved by Congress and 17 interim or acting leaders.

A number of those Administrators, and virtually all of the interim appointees, have been career agency managers, appointed primarily for their administrative capabilities. After all, the operational mechanics of contracting, managing funds, maintaining program integrity, staffing critical positions, etc., have to be "Job One." Some administrators, the ones most likely to have had even a limited public profile — like economists Carolyne Davis (1981-85) and Gail Wilensky (1990-92), hospital administrator Bruce Vladeck (1992-97) or physicians William Roper (1986-89) and Mark McClellan (2004-06) — have been healthcare policy experts drawn from public policy or economics, or from healthcare institutional settings. This latter group has on occasion been able to provide meaningful policy direction and innovation, but their ability to deliver real change has usually been constrained by the inertia of the giant CMS bureaucracy and partisan congressional conflict over the broad policy principles they advocated. CMS has been under interim leadership since McClellan’s resignation in November 2006.

Don Berwick brings a completely novel skill and experience set to the office. A pediatrician by training, he made his real professional mark as vice president of quality-of-care measurement at Harvard Community Health Plan in the early 1970s and went on to found the not-for-profit Institute for Healthcare Improvement in 1989. His is unquestionably the most highly regarded and influential healthcare quality improvement voice in the U.S. today, and the practical results of IHI-promoted voluntary initiatives such as the 100,000 Lives Campaign and the Five Million Lives Campaign in reducing medical errors and avoidable adverse events and patient deaths are truly remarkable. These programs are built on the three-legged stool of quality measurement, operations research and implementation of best practices. Berwick deals with concrete information about how to measure what goes on in healthcare institutions and how to design and implement changes in care delivery processes in order to improve efficiency, effectiveness and the quality of the experience for both patients and caregivers. No high-concept healthcare policy ideals here, no ideologically based principles or goals — just commitment to a solid grounding in where we are, where we want to be and how to get institutions to commit to the job of moving in the desired direction.

That’s why I believe Berwick has a chance to make an enormous difference. His approach bypasses the most important political pitfalls faced by prior efforts to meaningfully improve Medicare and Medicaid healthcare delivery. Healthcare quality improvement isn’t a political issue; Berwick’s approach to quality improvement doesn’t depend on politically controversial solutions such as capitation payment systems. He should have no trouble mobilizing the CMS bureaucracy to implement quality measurement in its contracting efforts. The groundwork for rewarding hospitals for quality performance is already in place and the opportunity to ratchet up the stakes is there. CMS can’t dictate operational reforms at the hospital level, but it can sponsor larger and more vigorous quality improvement demonstration projects. There is no one in the world better than Don Berwick at mobilizing support for and participation in such projects. There is no reason why, under Berwick’s direction, CMS shouldn’t become the exemplar for healthcare delivery innovation and quality promotion, and I think it will.

Quality promotion and improvement will help constrain the growth of costs, but won’t accomplish the whole task there. That’s another place where Don Berwick’s talents meet current needs so much better than his predecessors — the operations research piece of IHI’s toolkit. We’ll still be looking at the need to deal with system-wide over-utilization of services, cost-ineffective delivery systems, defensive medicine and a host of other factors that contribute to avoidable medical spending. Focus, for a moment, on the “avoidable” piece of that last sentence, because there is no way to avoid the fact that the Baby Boom cohort is entering its mid- to late-60s and that aging will be accompanied by a growing need for healthcare. We’d need to spend an awful lot less per person to make up for the impending explosion in the number of people needing high levels of medical services. But Berwick has demonstrated at IHI that there are tremendous efficiencies to be gained — efficiencies that also lead to predictability and quality — by applying operations research principles to hospital and physician practice processes for care delivery. Again, CMS can and likely will, under Berwick, be a leader in encouraging and providing incentives for the adoption of more efficient delivery models.

What does this mean for medical technology companies and innovators? Only good things. Successful pursuit of cost savings through medical error reduction, elimination of duplicative services, adoption of best practices and streamlining delivery systems for efficiency all help the medtech industry in two ways: Directly, by creating new markets and expanded opportunities for technologies that lower costs, enable improved operational efficiency and help reduce medical errors; and indirectly, by relieving the cost pressures that might, in time, lead to restrictions on the potential market or other innovative therapeutic and diagnostic innovations.

What’s the potential downside of the appointment? Berwick will need to prove himself as the CEO of an enormous enterprise. We know he can lead, innovate and inspire. We know he’s well-positioned to deal with Congress and has an enormous fund of goodwill in the healthcare policy and delivery worlds. But he will need to hold tight to the many operational pieces that make up CMS, including huge contracts with fiscal intermediaries, massive information systems upon which the functioning of one-third of the healthcare system rely, and relations and communications with 100 million-plus beneficiaries. He will need to put the right assistants and deputies into the right positions, oversee their work and take responsibility for management of the total mission. It isn’t an easy job, and the managerial track record isn’t there yet. Those who know him aren’t worried, but that’s where to look for signs of trouble

Edward Berger

Edward Berger is a senior healthcare executive with more than 25 years of experience in medical device reimbursement analysis, planning and advocacy. He’s the founder of Larchmont Strategic Advisors and the vice president of the Medical Development Group. Check him out at Larchmont Strategic Advisors.

Filed Under: Business/Financial News, News Well Tagged With: Larchmont Strategic Advisors, Reimbursement

In case you missed it

  • Bio-Rad recovering from ransomware attack
  • FDA clears first single-use duodenoscope from Boston Sci
  • FDA approves Tandem Diabetes’ advanced hybrid closed-loop controller
  • Awak Technologies raises $40m
  • Axonics raises additional $17m in public offering
  • Siemens Healthineers lands FDA clearance for two CT systems
  • Aethlon prices $5m offering
  • Sterigenics’ legal troubles mount in Illinois
  • In2Bones launches AlloAid BioNail
  • Caresyntax to acquire Syus; raises $45.6m
  • Nihon Kohden launches new patient monitor
  • Senate confirms Dr. Stephen Hahn to lead FDA
  • Iradimed renews CE mark for MRI-safe patient monitor
  • Flexicare recalls fiber optic laryngoscope blades and handles
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
  • TransEnterix announces reverse split of common stock
  • GI Windows raises $15m Series A

RSS From Medical Design & Outsourcing

  • Siemens Healthineers lands FDA clearance for two CT systems
    Siemens Healthineers this week said it won FDA clearance for its Somatom go.Sim and Somtom go.Open Pro computed tomography systems. The CT systems are designed for radiation therapy planning and are members of the company’s Somatom go. platform of devices. Siemens Healthineers’ platform uses hardware and software components like patient marking lasers and automated quality… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns who spend […]
  • Sterigenics’ legal troubles mount in Illinois
    Nearly two dozen new lawsuits were filed against Sterigenics this week over its now-shuttered ethylene oxide (EtO) sterilization plant in Willowbrook, Ill., according to a law firm representing some of the plaintiffs. That brings the total of such lawsuits to nearly 75, noted Chicago personal injury lawyer Antonio Romanucci, court-appointed lead counsel from among five… […]
  • In2Bones launches AlloAid BioNail
    In2Bones this week launched its AlloAid BioNail sterile allograft implant. The implant is designed to give rigid, stable fixation during hand and foot reconstruction. AlloAid BioNail is made from strong cortical allografts to provide osteoconductive properties for bone remodeling and healing. It features a tapered point and multiple, contoured wedge facets to ease insertion, anchor… […]
  • Protolabs’ healthcare grant spurs 2 feeding tube inventions
    Digital manufacturer Protolabs (NYSE:PRLB) announced today that MedStar Health (Columbia, Md.) and Cleveland Clinic Innovations are joint winners of the company’s Cool Idea Award: Healthcare Grant. These grants provide in-kind manufacturing services to the support development of medical products to spur innovation in the field. MedStar Health’s gravity-feed syringe holder simplifies the feeding of newborns… […]
  • Nihon Kohden launches new patient monitor
    Nihon Kohden (TYO:6849) announced the U.S. launch of its Life Scope SVM-7200 series vital signs monitor for outpatient facilities and beds that aren’t continuously monitored. The Life Scope SVM-7200 is designed to provide customizable early warning scoring to help clinicians identify patients who are deteriorating or at risk of deterioration. It combines vital signs data with… […]
  • Senate confirms Dr. Stephen Hahn to lead FDA
    The U.S. Senate has confirmed Dr. Stephen Hahn as the next commissioner of the FDA. The vote was 72 to 18, according to a report in the New York Times. Hahn will be the first permanent commissioner of the agency since Dr. Scott Gottlieb resigned in April. President Trump nominated Hahn, the chief medical officer at Houston’s… […]
  • 3M to sell drug-delivery biz to Altaris Capital Partners for $650m
    3M (NYSE:MMM) announced today that it entered into an agreement to sell most of its drug-delivery business to an affiliate of Altaris Capital Partners for approximately $650 million. St. Paul, Minn.-based 3M will retain its transdermal drug delivery components business, according to a news release. The business being divested has annual global sales reaching approximately… […]
  • Lawsuit endangers Sterigenics consent order in Georgia
    A consent order that Sterigenics entered into with the state of Georgia to reduce ethylene oxide (EtO) emissions at its Atlanta medtech sterilization plant may be in jeopardy. A hearing is scheduled today on a lawsuit that accuses the Georgia Environmental Protection Division (EPD) of failing to take public comment before entering the Aug. 7… […]
  • Trelleborg acquires Tritec Seal
    Trelleborg Sealing Solutions said today it has closed on its acquisition of rotary seal manufacturer Tritec Seal, which produces engineered polytetrafluoroethylene (PTFE) sealing solutions. Trelleborg said the acquisition strengthens its product portfolio while giving the business area access to increased manufacturing capacity. Headquartered in Fenton, Mich., with additional manufacturing in Giddings, Texas, Tritec Seal generated… […]
  • RSNA 2019: 7 radiology innovations you need to know
    Nearly 53,000 people attended the 2019 Radiological Society of North America annual meeting in Chicago last week. And they heard the same acronym over and over again: AI. Exhibitors at the conference touted their artificial-intelligence-enhanced technology at every turn, claiming to make images clearer, sharper, easier to use and powerful enough to help clinicians make… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS